
About Positive Mind B9 Pharma Private Limited
Data last updated:
Positive Mind B9 Pharma Private Limited is a private limited company based in Triplicane, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2022.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2022PTC150597.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Appao Vidyasagar and G Indira Sagar.
Its last annual general meeting (AGM) was held on 07 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 38/57 Ff2 Devaraj Street, Triplicane, Tamil Nadu, India – 600005.
The company is associated with 1 brand: Positivemindb9Pharma.
For more details, the company can be reached via its website positivemindb9pharma.com.
Company details
Recognitions & Rankings of Positive Mind B9 Pharma
Contact details
Positive Mind B9 Pharma Private Limited's registered office is in Triplicane, Tamil Nadu.
- Social Media
- Registered Address38/57 Ff2 Devaraj Street, Triplicane, Tamil Nadu, India – 600005
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Positive Mind B9 Pharma operates one associated brand: Positivemindb9Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Licenses, markets, and distributes innovative patented drugs in India. | positivemindb9pharma.com |
Financials of Positive Mind B9 Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Positive Mind B9 Pharma Private Limited, buy the company report.
Board of directors of Positive Mind B9 Pharma Private Limited
Positive Mind B9 Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Appao Vidyasagar | Director | 16 Mar 2022 | 4 Years 8 Months | Current |
| G Indira Sagar | Director | 16 Mar 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Positive Mind B9 Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Positive Mind B9 Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Positive Mind B9 Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Positive Mind B9 Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Appao Vidyasagar was appointed as Director on 16 Mar 2022.
Frequently asked questions
Positive Mind B9 Pharma is an active private limited company based in Triplicane, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2022 (4+ years old) and is registered under CIN U24230TN2022PTC150597.
Positive Mind B9 Pharma has 2 current directors:
- Appao Vidyasagar - Director
- G Indira Sagar - Director
The latest financial statements of Positive Mind B9 Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 August 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Positive Mind B9 Pharma is U24230TN2022PTC150597. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Positive Mind B9 Pharma was incorporated on 16 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Chennai.
Appao Vidyasagar was appointed as Director on 16 Mar 2022. G Indira Sagar was appointed as Director on 16 Mar 2022.
Yes, Positive Mind B9 Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Positive Mind B9 Pharma can be reached through the website positivemindb9pharma.com. Its registered office is in Triplicane, Tamil Nadu, India.
The registered office of Positive Mind B9 Pharma is at 3857 Ff2 Devaraj Street, Triplicane, Tamil Nadu, India – 600005.
Positive Mind B9 Pharma operates in the pharma industry, in the drug formulation and development segment.

